Sree Kant

Head of Strategy - External Science & Innovation, Pfizer

Sree Kant is the Head of Strategy for Pfizer’s External Science & Innovation group, leading partnering strategy across different therapeutic areas/technologies and geographies. He is focused on innovative partnerships, especially in the early stages with different partners (VC, biotech, academia, and foundations) to drive emerging science and breakthrough technologies

Before joining Pfizer, he was a Principal at the Boston Consulting Group advising large pharma and biotech on R&D strategy as well as large M&A. Sree has also worked with two healthcare startups and a generic pharmaceutical company in India and the UK. He has an MBA from the Indian Institute of Management, and an MPH from the Harvard School of Public Health.

My Sessions

Roundtable | Pharma Weighs In – Tech Innovations & How to Partner

Among other topics, this session will cover: Working with an informed consumer The ‘retail mindset’ transforming healthcare How big pharma partners with startups What are the new and innovative technologies that are appealing to big pharma How has pharma’s partnership strategy evolved over time? What does Pharma care about most while looking at early stage investments? […]